» Articles » PMID: 11824976

The Effect of High Salt Concentration on Detection of Serum Immune Complexes and Autoantibodies to C1q in Patients with Systemic Lupus Erythematosus

Overview
Journal J Rheumatol
Specialty Rheumatology
Date 2002 Feb 5
PMID 11824976
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare the binding of immune complexes and anti-Clq in systemic lupus erythematosus (SLE) sera to Clq and to the purified collagen-like region of Clq (CLR) in high and physiologic NaCl concentrations.

Methods: Sera from patients with SLE were tested for binding of IgG to Clq and to CLR in physiologic (0.15 M NaCl) or high (1.0 M NaCl) salt concentration. Sera were ultracentrifuged to separate monomeric IgG and high molecular weight IgG (immune complexes), and fractions were tested for binding to C1q and to CLR in the presence of physiologic or high salt concentrations.

Results: Decrease in binding of immune complexes to Clq in the presence of high salt ranged from 0 to 96.8%, with a median of 48.4%. Decrease of the binding of monomeric IgG to C1q in the presence of high salt ranged from 2.2 to 74.3%, with a median of 46.2%. Binding of monomeric autoantibodies to CLR also was decreased by high salt. Nevertheless, anti-Clq measured by binding to CLR in physiologic salt correlated highly with the binding to Clq in both physiologic (r = 0.978) and high salt (r = 0.983).

Conclusion: Clq-binding of immune complexes in SLE sera is not uniformly abrogated by high salt and binding of autoantibodies to CLR is variably reduced by high salt. Binding of IgG to Clq in high salt correlates with but is not equivalent to quantifying these autoantibodies by binding to CLR.

Citing Articles

Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation.

Dijkstra D, van de Bovenkamp F, Abendstein L, Zuijderduijn R, Pool J, Kramer C Proc Natl Acad Sci U S A. 2023; 120(50):e2310666120.

PMID: 38048459 PMC: 10723154. DOI: 10.1073/pnas.2310666120.


Anti-C1q Autoantibodies: Standard Quantification and Innovative ELISA.

Csorba K, Schirmbeck L, Dubler D, Trendelenburg M Methods Mol Biol. 2021; 2227:107-114.

PMID: 33847935 DOI: 10.1007/978-1-0716-1016-9_10.


Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site.

Csorba K, Schirmbeck L, Tuncer E, Ribi C, Roux-Lombard P, Chizzolini C Front Immunol. 2019; 10:2619.

PMID: 31787984 PMC: 6853867. DOI: 10.3389/fimmu.2019.02619.


Anti-C1q in systemic lupus erythematosus.

Stojan G, Petri M Lupus. 2016; 25(8):873-7.

PMID: 27252264 PMC: 7523495. DOI: 10.1177/0961203316645205.


Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare.

Birmingham D, Bitter J, Ndukwe E, Dials S, Gullo T, Conroy S Clin J Am Soc Nephrol. 2015; 11(1):47-53.

PMID: 26700439 PMC: 4702227. DOI: 10.2215/CJN.03990415.